{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01777243: Phase 1 Interventional Completed Amyloidosis
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02349451: Phase 2 Interventional Completed Psoriatic Arthritis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00001564: Phase 2 Interventional Completed Ewing's Sarcoma
(1996)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02279498: Phase 3 Interventional Completed Exocrine Pancreatic Insufficiency
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03463187: Phase 1/Phase 2 Interventional Completed Moderate-to-severe Chronic Plaque Psoriasis
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02119819: Phase 2 Interventional Completed Diabetes Mellitus, Type 2
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04668300: Phase 2 Interventional Recruiting Metastatic Angiosarcoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01280903: Not Applicable Interventional Completed Osteoarthritis, Knee
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03188887: Phase 3 Interventional Completed IgA Nephropathy
(2018)
Source URL:
Class:
PROTEIN
